Jun.07 — 23andMe Inc. CEO Anne Wojcicki discusses the company’s latest finding of a genetic variant associated with the loss of smell and taste among Covid-19 patients. The research follows 23andMe’s earlier report on the link between human blood types and susceptibility to the virus. She also shares the areas of research the company is working on to have a deeper understanding of Covid-19 severity and symptoms. Wojcicki speaks to Emily Chang on “Bloomberg Technology.”
source
Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.
This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.